Clinical Trial Update: Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 study evaluating phenoxodiol in combination with cisplatin or paclitaxel for recurrent ovarian epithelial, fallopian tube, or primar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)
• Phenoxodiol

Snippet

Sponsor: MEI Pharma, Inc. | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED